Literature DB >> 7416114

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

J F Bale, C Brasher, R L Siegler.   

Abstract

To define the CNS manifestations of the hemolytic-uremic syndrome (HUS), the records of 61 consecutive episodes of HUS in 60 patients were reviewed. Major CNS signs (seizures and/or coma) occurred in 30 of the 61 episodes. Twenty-four children had seizures. Analysis of blood pressure and metabolic parameters or admission to the hospital did not predict which child would exhibit CNS signs. However, during the subsequent course of the illness, children with CNS dysfunction had lower minimum serum sodium concentrations and more severe azotemia and were more likely to require dialysis than children without CNS signs. Of the 61 episodes, there were three deaths, and three children suffered major CNS sequelae. Coma at the time of admission and elevated CSF protein levels were features associated with poor outcome.

Entities:  

Mesh:

Year:  1980        PMID: 7416114     DOI: 10.1001/archpedi.1980.02130210053014

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  45 in total

1.  Acute neurology and neurophysiology of haemolytic-uraemic syndrome.

Authors:  K J Eriksson; S G Boyd; R C Tasker
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Shiga toxins induce autophagy leading to differential signalling pathways in toxin-sensitive and toxin-resistant human cells.

Authors:  Moo-Seung Lee; Rama P Cherla; Matthew H Jenson; Dinorah Leyva-Illades; Margarita Martinez-Moczygemba; Vernon L Tesh
Journal:  Cell Microbiol       Date:  2011-07-04       Impact factor: 3.715

Review 3.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

4.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

5.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

Authors:  C M Taylor; R H White; M H Winterborn; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

6.  Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report.

Authors:  R Bogdanović; A Cvorić; V Nikolić; M Sindjić
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

7.  Haemolytic-uraemic syndrome presenting as an acute abdomen.

Authors:  P M Lamont; A I Davidson
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

Review 8.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

9.  Haemolytic-uraemic syndrome with thrombotic microangiopathy of the retina following cytomegalovirus infection: postmortem findings.

Authors:  B Catón; R Díaz de Otazu; M Aldamiz-Echebarria; A Viguri
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

10.  The hemolytic-uremic syndrome.

Authors:  C Brasher; R L Siegler
Journal:  West J Med       Date:  1981-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.